These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 36014874)

  • 1. Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs.
    Malík M; Tlustoš P
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nootropic Herbs, Shrubs, and Trees as Potential Cognitive Enhancers.
    Malík M; Tlustoš P
    Plants (Basel); 2023 Mar; 12(6):. PubMed ID: 36987052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nootropic drugs: Methylphenidate, modafinil and piracetam - Population use trends, occurrence in the environment, ecotoxicity and removal methods - A review.
    Wilms W; Woźniak-Karczewska M; Corvini PF; Chrzanowski Ł
    Chemosphere; 2019 Oct; 233():771-785. PubMed ID: 31200137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of nootropic drugs with cholinergic activity in treatment of cognitive deficit: a review.
    Colucci L; Bosco M; Rosario Ziello A; Rea R; Amenta F; Fasanaro AM
    J Exp Pharmacol; 2012; 4():163-72. PubMed ID: 27186129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nootropics: preclinical results in the light of clinical effects; comparison with tacrine.
    Mondadori C
    Crit Rev Neurobiol; 1996; 10(3-4):357-70. PubMed ID: 8978986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards better brain management: nootropics.
    Malik R; Sangwan A; Saihgal R; Jindal DP; Piplani P
    Curr Med Chem; 2007; 14(2):123-31. PubMed ID: 17266573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plant-derived nootropics and human cognition: A systematic review.
    Lorca C; Mulet M; Arévalo-Caro C; Sanchez MÁ; Perez A; Perrino M; Bach-Faig A; Aguilar-Martínez A; Vilella E; Gallart-Palau X; Serra A
    Crit Rev Food Sci Nutr; 2023; 63(22):5521-5545. PubMed ID: 34978226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In search of the mechanism of action of the nootropics: new insights and potential clinical implications.
    Mondadori C
    Life Sci; 1994; 55(25-26):2171-8. PubMed ID: 7997076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic.
    Suliman NA; Mat Taib CN; Mohd Moklas MA; Adenan MI; Hidayat Baharuldin MT; Basir R
    Evid Based Complement Alternat Med; 2016; 2016():4391375. PubMed ID: 27656235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs.
    Gualtieri F; Manetti D; Romanelli MN; Ghelardini C
    Curr Pharm Des; 2002; 8(2):125-38. PubMed ID: 11812254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive enhancers (Nootropics). Part 1: drugs interacting with receptors. Update 2014.
    Froestl W; Muhs A; Pfeifer A
    J Alzheimers Dis; 2014; 41(4):961-1019. PubMed ID: 24898652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive enhancers (nootropics). Part 2: drugs interacting with enzymes.
    Froestl W; Muhs A; Pfeifer A
    J Alzheimers Dis; 2013; 33(3):547-658. PubMed ID: 23042218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive enhancers (nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. disease-modifying drugs.
    Froestl W; Pfeifer A; Muhs A
    J Alzheimers Dis; 2013; 34(1):1-114. PubMed ID: 23186990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals.
    Schifano F; Catalani V; Sharif S; Napoletano F; Corkery JM; Arillotta D; Fergus S; Vento A; Guirguis A
    Drugs; 2022 Apr; 82(6):633-647. PubMed ID: 35366192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive enhancers (nootropics). Part 1: drugs interacting with receptors.
    Froestl W; Muhs A; Pfeifer A
    J Alzheimers Dis; 2012; 32(4):793-887. PubMed ID: 22886028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nootropic drug evaluation for general practice].
    Ihl R; Kretschmar C
    Nervenarzt; 1997 Nov; 68(11):853-61. PubMed ID: 9732727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unauthorized ingredients in "nootropic" dietary supplements: A review of the history, pharmacology, prevalence, international regulations, and potential as doping agents.
    Jędrejko K; Catlin O; Stewart T; Anderson A; Muszyńska B; Catlin DH
    Drug Test Anal; 2023 Aug; 15(8):803-839. PubMed ID: 37357012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nootropic and Anti-Alzheimer's Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer's Neuropathology.
    Uddin MS; Al Mamun A; Kabir MT; Jakaria M; Mathew B; Barreto GE; Ashraf GM
    Mol Neurobiol; 2019 Jul; 56(7):4925-4944. PubMed ID: 30414087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plant metabolites as nootropics and cognitives].
    Cervenka F; Jahodár L
    Ceska Slov Farm; 2006 Sep; 55(5):219-29. PubMed ID: 17128592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain Ageing, Cognition and Diet: A Review of the Emerging Roles of Food-Based Nootropics in Mitigating Age-related Memory Decline.
    Onaolapo AY; Obelawo AY; Onaolapo OJ
    Curr Aging Sci; 2019; 12(1):2-14. PubMed ID: 30864515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.